Stockscreener 앱 받기
0.367
7.06%
0.0242
전일 마감가:
$0.3428
열려 있는:
$0.347
하루 거래량:
1.45M
Relative Volume:
0.52
시가총액:
$14.54M
수익:
$62.71M
순이익/손실:
$-10.48M
주가수익비율:
-0.5825
EPS:
-0.63
순현금흐름:
$-13.77M
1주 성능:
+9.23%
1개월 성능:
+1.94%
6개월 성능:
-42.39%
1년 성능:
-91.41%
1일 변동 폭
$0.3459
$0.3839
1주일 범위
$0.324
$0.3839
52주 변동 폭
$0.2179
$4.27
프로페이즈 Stock (PRPH) Company Profile
명칭
Prophase Labs Inc
전화
(215) 345-0919
주소
711 STEWART AVE, SUITE 200, NEW YORK, PA
PRPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRPH
Prophase Labs Inc
|
0.367 | 14.54M | 62.71M | -10.48M | -13.77M | -0.63 |
|
TMO
Thermo Fisher Scientific Inc
|
408.28 | 156.49B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
198.80 | 145.01B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
531.32 | 42.30B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
119.17 | 34.24B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
157.47 | 27.64B | 15.50B | 1.33B | 2.16B | 7.34 |
프로페이즈 Stock (PRPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-12-20 | 개시 | H.C. Wainwright | Buy |
| 2021-10-13 | 다운그레이드 | Dawson James | Buy → Neutral |
| 2021-01-20 | 개시 | Dawson James | Buy |
프로페이즈 주식(PRPH)의 최신 뉴스
ProPhase Labs Announces Successful Study Demonstrating Performan - GuruFocus
ProPhase Labs (PRPH) Advances with Positive Validation of BE-Smart Test | PRPH Stock News - GuruFocus
Prophase Labs Announces Successful Study Demonstrating Performance Of Be-Smart(TM) Test In Detecting Esophageal Cancer - MarketScreener
ProPhase Labs Inc. Validates BE-Smart™ Diagnostic Test for Esophageal Disease with Over 95% Success Rate - Nasdaq
ProPhase Labs Announces Successful Study Demonstrating - GlobeNewswire
Breakthrough: ProPhase's New Cancer Test Shows 95% Success Rate, Targets $10B Market - Stock Titan
ProPhase Labs Inc (PRPH)’s Market Momentum: Closing Strong at 0.33, Down -2.56 - DWinneX
ProPhase Labs, Inc. (NASDAQ:PRPH) Q1 2025 Earnings Call Transcript - MSN
52,394 Shares in ProPhase Labs, Inc. (NASDAQ:PRPH) Acquired by Squarepoint Ops LLC - Defense World
ProPhase Labs Announces Formation of Clinical Science Advisory B - GuruFocus
ProPhase Labs (PRPH) Forms Advisory Board to Propel BE-Smart Tes - GuruFocus
ProPhase Labs (PRPH) Forms Advisory Board to Propel BE-Smart Test Commercialization | PRPH Stock News - GuruFocus
ProPhase Labs Announces Formation of Clinical Science Advisory Board to Accelerate Commercialization of BE-SmartTM Esophageal Disease Diagnostic Platform | PRPH Stock News - GuruFocus
ProPhase Labs Inc. Establishes Clinical Science Advisory Board to Advance BE-SmartTM Test for Esophageal Disease Detection - Nasdaq
ProPhase Labs forms advisory board for esophageal test - Investing.com
ProPhase Labs Announces Formation of Clinical Science - GlobeNewswire
ProPhase Labs Targets $14 Billion Market with Revolutionary Esophageal Cancer Detection Platform - Stock Titan
HBIXHarvest: Bitcoin Enhanced Income ETF - The Globe and Mail
ProPhase Labs’ Earnings Call: Strategic Moves Amid Challenges - TipRanks
ProPhase Labs Inc (PRPH) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial Challenges - Yahoo Finance
ProPhase Labs Inc (PRPH) Q1 2025 Earnings Call Highlights: Strat - GuruFocus
ProPhase Labs Reports Q1 2025 Earnings and Strategic Developments - TipRanks
Transcript : ProPhase Labs, Inc., Q1 2025 Earnings Call, May 20, 2025 - marketscreener.com
ProPhase Labs, Inc. SEC 10-Q Report - TradingView
Earnings call transcript: ProPhase Labs beats Q1 2025 EPS forecast, stock rises - Investing.com
ProPhase Labs earnings beat by $0.05, revenue fell short of estimates - Investing.com Canada
Prophase Labs Inc reports results for the quarter ended March 31Earnings Summary - TradingView
ProPhase Labs, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
ProPhase (PRPH) Awaits Potential $50 Million Insurance Recovery - GuruFocus
ProPhase (PRPH) Awaits Potential $50 Million Insurance Recovery | PRPH Stock News - GuruFocus
ProPhase (PRPH) Explores Strategic Sale of Nebula Genomics | PRPH Stock News - GuruFocus
ProPhase Labs (PRPH) Anticipates Extension for Nasdaq Listing | PRPH Stock News - GuruFocus
PRPH Streamlines Operations with Strategic Changes | PRPH Stock News - GuruFocus
ProPhase Labs Announces Financial Results for the Three Months E - GuruFocus
ProPhase Labs Inc Reports Q1 2025 EPS of $(0.13) and Revenue of $1.4 Million, Missing Estimates - GuruFocus
ProPhase Labs (PRPH) Focuses on Strategic Growth Amid Revenue De - GuruFocus
PROPHASE LABS Earnings Results: $PRPH Reports Quarterly Earnings - Nasdaq
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2025 | PRPH Stock News - GuruFocus
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2025 - GlobeNewswire
ProPhase Labs Slashes Costs by $8M, Reveals Three Major Value Drivers Including Potential $50M Collection - Stock Titan
ProPhase Labs Delays Form 10-Q Filing - TipRanks
ProPhase Labs Inc. to Present First Quarter 2025 Financial Results on May 20, 2025 - GlobeNewswire
ProPhase Labs, Inc. (NASDAQ:PRPH) Shares Bought by Renaissance Technologies LLC - Defense World
ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2024 Earnings Call Transcript - MSN
Geode Capital Management LLC Boosts Stake in ProPhase Labs, Inc. (NASDAQ:PRPH) - Defense World
PRPHProphase Labs Inc Latest Stock News & Market Updates - Stock Titan
PRPH’s Stock Market Puzzle: Piecing Together 2023’s Performance - investchronicle.com
There is no doubt that ProPhase Labs Inc (PRPH) ticks all the boxes. - Sete News
Metric Analysis: ProPhase Labs Inc (PRPH)’s Key Ratios in the Limelight - DWinneX
What was ProPhase Labs Inc (PRPH)’s performance in the last session? - uspostnews.com
Press Release Distribution & PR Platform - ACCESS Newswire
프로페이즈 (PRPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.43%
0.70%
자본화:
|
볼륨(24시간):